Do pediatric headaches respond to bilateral lower cervical paraspinous bupivacaine injections?

Larry B. Mellick, Michelle R. Pleasant

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Objective: Bilateral lower cervical paraspinous intramuscular bupivacaine injections have recently been reported as a therapeutic modality for headache pain in adult patients presenting to an emergency department. In this study, we accomplished a retrospective review of all pediatric patients with headaches who were treated with this technique in an emergency department setting over a 16-month period. The therapeutic response of all pediatric patients who received bilateral lower cervical paraspinous intramuscular bupivacaine injections for headache pain is described in this article. Methods: Three separate databases were reviewed to capture all patients younger than 18 years with a diagnosis of headache who received bilateral cervical injections between June 30, 2003, and December 1, 2004, in the Medical College of Georgia and Children's Medical Center emergency departments. Their medical records were retrospectively reviewed to determine their response to this procedure. Results: The headaches of 13 patients younger than 18 years were treated with this procedure. The mean headache severity was 9.15, and the mean duration of headache was 3.16 days. Six (46.2%) of 13 patients had complete relief of their headaches, whereas 5 (38.4%) of 13 patients had partial relief. No significant relief was documented in 2 (15.4%) of 13 patients. A therapeutic response was documented in 11 (84.6%) of 13 of the patients. Conclusions: These retrospective observations suggest that bilateral lower cervical paraspinous intramuscular injections with small amounts of bupivacaine may have a therapeutic role in the management of headache pain in children, and their rate of therapeutic response may be similar to that recently reported for adult headache patients.

Original languageEnglish (US)
Pages (from-to)192-196
Number of pages5
JournalPediatric emergency care
Volume26
Issue number3
DOIs
StatePublished - Mar 1 2010

Fingerprint

Bupivacaine
Headache
Pediatrics
Injections
Intramuscular Injections
Hospital Emergency Service
Therapeutics
Pain
Pain Management
Medical Records
Databases

Keywords

  • Bupivacaine
  • Cervical
  • Headache
  • Injections
  • Intramuscular
  • Migraine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Emergency Medicine

Cite this

Do pediatric headaches respond to bilateral lower cervical paraspinous bupivacaine injections? / Mellick, Larry B.; Pleasant, Michelle R.

In: Pediatric emergency care, Vol. 26, No. 3, 01.03.2010, p. 192-196.

Research output: Contribution to journalReview article

Mellick, Larry B. ; Pleasant, Michelle R. / Do pediatric headaches respond to bilateral lower cervical paraspinous bupivacaine injections?. In: Pediatric emergency care. 2010 ; Vol. 26, No. 3. pp. 192-196.
@article{3b4532659f784ee9915cb47e0c77dc76,
title = "Do pediatric headaches respond to bilateral lower cervical paraspinous bupivacaine injections?",
abstract = "Objective: Bilateral lower cervical paraspinous intramuscular bupivacaine injections have recently been reported as a therapeutic modality for headache pain in adult patients presenting to an emergency department. In this study, we accomplished a retrospective review of all pediatric patients with headaches who were treated with this technique in an emergency department setting over a 16-month period. The therapeutic response of all pediatric patients who received bilateral lower cervical paraspinous intramuscular bupivacaine injections for headache pain is described in this article. Methods: Three separate databases were reviewed to capture all patients younger than 18 years with a diagnosis of headache who received bilateral cervical injections between June 30, 2003, and December 1, 2004, in the Medical College of Georgia and Children's Medical Center emergency departments. Their medical records were retrospectively reviewed to determine their response to this procedure. Results: The headaches of 13 patients younger than 18 years were treated with this procedure. The mean headache severity was 9.15, and the mean duration of headache was 3.16 days. Six (46.2{\%}) of 13 patients had complete relief of their headaches, whereas 5 (38.4{\%}) of 13 patients had partial relief. No significant relief was documented in 2 (15.4{\%}) of 13 patients. A therapeutic response was documented in 11 (84.6{\%}) of 13 of the patients. Conclusions: These retrospective observations suggest that bilateral lower cervical paraspinous intramuscular injections with small amounts of bupivacaine may have a therapeutic role in the management of headache pain in children, and their rate of therapeutic response may be similar to that recently reported for adult headache patients.",
keywords = "Bupivacaine, Cervical, Headache, Injections, Intramuscular, Migraine",
author = "Mellick, {Larry B.} and Pleasant, {Michelle R.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1097/PEC.0b013e3181d1e162",
language = "English (US)",
volume = "26",
pages = "192--196",
journal = "Pediatric Emergency Care",
issn = "0749-5161",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Do pediatric headaches respond to bilateral lower cervical paraspinous bupivacaine injections?

AU - Mellick, Larry B.

AU - Pleasant, Michelle R.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Objective: Bilateral lower cervical paraspinous intramuscular bupivacaine injections have recently been reported as a therapeutic modality for headache pain in adult patients presenting to an emergency department. In this study, we accomplished a retrospective review of all pediatric patients with headaches who were treated with this technique in an emergency department setting over a 16-month period. The therapeutic response of all pediatric patients who received bilateral lower cervical paraspinous intramuscular bupivacaine injections for headache pain is described in this article. Methods: Three separate databases were reviewed to capture all patients younger than 18 years with a diagnosis of headache who received bilateral cervical injections between June 30, 2003, and December 1, 2004, in the Medical College of Georgia and Children's Medical Center emergency departments. Their medical records were retrospectively reviewed to determine their response to this procedure. Results: The headaches of 13 patients younger than 18 years were treated with this procedure. The mean headache severity was 9.15, and the mean duration of headache was 3.16 days. Six (46.2%) of 13 patients had complete relief of their headaches, whereas 5 (38.4%) of 13 patients had partial relief. No significant relief was documented in 2 (15.4%) of 13 patients. A therapeutic response was documented in 11 (84.6%) of 13 of the patients. Conclusions: These retrospective observations suggest that bilateral lower cervical paraspinous intramuscular injections with small amounts of bupivacaine may have a therapeutic role in the management of headache pain in children, and their rate of therapeutic response may be similar to that recently reported for adult headache patients.

AB - Objective: Bilateral lower cervical paraspinous intramuscular bupivacaine injections have recently been reported as a therapeutic modality for headache pain in adult patients presenting to an emergency department. In this study, we accomplished a retrospective review of all pediatric patients with headaches who were treated with this technique in an emergency department setting over a 16-month period. The therapeutic response of all pediatric patients who received bilateral lower cervical paraspinous intramuscular bupivacaine injections for headache pain is described in this article. Methods: Three separate databases were reviewed to capture all patients younger than 18 years with a diagnosis of headache who received bilateral cervical injections between June 30, 2003, and December 1, 2004, in the Medical College of Georgia and Children's Medical Center emergency departments. Their medical records were retrospectively reviewed to determine their response to this procedure. Results: The headaches of 13 patients younger than 18 years were treated with this procedure. The mean headache severity was 9.15, and the mean duration of headache was 3.16 days. Six (46.2%) of 13 patients had complete relief of their headaches, whereas 5 (38.4%) of 13 patients had partial relief. No significant relief was documented in 2 (15.4%) of 13 patients. A therapeutic response was documented in 11 (84.6%) of 13 of the patients. Conclusions: These retrospective observations suggest that bilateral lower cervical paraspinous intramuscular injections with small amounts of bupivacaine may have a therapeutic role in the management of headache pain in children, and their rate of therapeutic response may be similar to that recently reported for adult headache patients.

KW - Bupivacaine

KW - Cervical

KW - Headache

KW - Injections

KW - Intramuscular

KW - Migraine

UR - http://www.scopus.com/inward/record.url?scp=77949355134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949355134&partnerID=8YFLogxK

U2 - 10.1097/PEC.0b013e3181d1e162

DO - 10.1097/PEC.0b013e3181d1e162

M3 - Review article

C2 - 20179659

AN - SCOPUS:77949355134

VL - 26

SP - 192

EP - 196

JO - Pediatric Emergency Care

JF - Pediatric Emergency Care

SN - 0749-5161

IS - 3

ER -